Takashi Kijima

Hyogo Medical University — Japan

Medicine · Health Sciences

34h-index5.3kcitations389works1.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Treatments and Mutations(133), Cancer Immunotherapy and Biomarkers(100), Occupational and environmental lung diseases(76), Lung Cancer Research Studies(69), Pleural and Pulmonary Diseases(56)

Publications389 total

Radiofrequency Ablation for Recurrent Pleural Mesothelioma
Preprints.org·2025Open Access
Selecting optimal immunotherapy based on inflammation in stage IV PD-L1 ≥50% gene mutation-negative non-small cell lung cancer: pembrolizumab monotherapy versus combination chemoimmunotherapy
Translational Lung Cancer Research·2025Open Access
Efficacy and Safety of Chemoimmunotherapy in Patients With Advanced Non-small Cell Lung Cancer With Pre-existing Interstitial Pneumonia and Low PD-L1 Expression
Anticancer Research·2025
Radiotherapy-free pembrolizumab combined with chemotherapy for locally advanced non-small-cell lung cancer with PD-L1 tumour proportion score of 50% or higher (Evolution trial): a multicentre, single-arm, phase 2 study
The Lancet Oncology·2025· 1 cited
Combined Compression and Cooling Therapy for Taxane Chemotherapy-induced Peripheral Neuropathy in Lung Cancer
Anticancer Research·2025Open Access
Salvage resection after immunotherapy for giant undifferentiated pleomorphic sarcoma of the chest wall
Journal of Surgical Case Reports·2025Open Access
Supplementary Table S9 from Chemoimmunotherapy Outcomes and Prognostic Factors in Patients with Advanced, Low PD-L1–Expressing Non–Small Cell Lung Cancer
2025Open Access
Supplementary Table S2 from Chemoimmunotherapy Outcomes and Prognostic Factors in Patients with Advanced, Low PD-L1–Expressing Non–Small Cell Lung Cancer
2025Open Access
Figure 3 from Chemoimmunotherapy Outcomes and Prognostic Factors in Patients with Advanced, Low PD-L1–Expressing Non–Small Cell Lung Cancer
2025Open Access
Figure 2 from Chemoimmunotherapy Outcomes and Prognostic Factors in Patients with Advanced, Low PD-L1–Expressing Non–Small Cell Lung Cancer
2025Open Access
Supplementary Table S5 from Chemoimmunotherapy Outcomes and Prognostic Factors in Patients with Advanced, Low PD-L1–Expressing Non–Small Cell Lung Cancer
2025Open Access
Figure 1 from Chemoimmunotherapy Outcomes and Prognostic Factors in Patients with Advanced, Low PD-L1–Expressing Non–Small Cell Lung Cancer
2025Open Access
Supplementary Table S4 from Chemoimmunotherapy Outcomes and Prognostic Factors in Patients with Advanced, Low PD-L1–Expressing Non–Small Cell Lung Cancer
2025Open Access
Supplementary Table S3 from Chemoimmunotherapy Outcomes and Prognostic Factors in Patients with Advanced, Low PD-L1–Expressing Non–Small Cell Lung Cancer
2025Open Access
Table 4 from Chemoimmunotherapy Outcomes and Prognostic Factors in Patients with Advanced, Low PD-L1–Expressing Non–Small Cell Lung Cancer
2025Open Access
Supplementary Figure S2 from Chemoimmunotherapy Outcomes and Prognostic Factors in Patients with Advanced, Low PD-L1–Expressing Non–Small Cell Lung Cancer
2025Open Access
Supplementary Table S10 from Chemoimmunotherapy Outcomes and Prognostic Factors in Patients with Advanced, Low PD-L1–Expressing Non–Small Cell Lung Cancer
2025Open Access
Supplementary Table S8 from Chemoimmunotherapy Outcomes and Prognostic Factors in Patients with Advanced, Low PD-L1–Expressing Non–Small Cell Lung Cancer
2025Open Access
Supplementary Methods from Chemoimmunotherapy Outcomes and Prognostic Factors in Patients with Advanced, Low PD-L1–Expressing Non–Small Cell Lung Cancer
2025Open Access
Figure 4 from Chemoimmunotherapy Outcomes and Prognostic Factors in Patients with Advanced, Low PD-L1–Expressing Non–Small Cell Lung Cancer
2025Open Access
page 1 of 20Next →

Frequent Co-authors

Isao Tachibana(23), Yoshito Takeda(22), Hiroshi Kida(17), Atsushi Kumanogoh(17), Izumi Nagatomo(16), Toru Kumagai(15), Ichiro Kawase(14), Haruhiko Hirata(13), Ryo Takahashi(10), Toshiyuki Minami(10), Mayumi Suzuki(9), Ravi Salgia(8), Takeo Iwasaki(8), Mitsuhiro Yoshida(8), Tadashi Osaki(8), Yasushi Otani(8), Koji Inoue(8), Kazuyuki Tsujino(7), Takayuki Takimoto(6), Seigo Minami(6)